Nephurocare Pharma Private Limited, a active private limited company, was established on 11 November 2010 in Ahmedabad, Gujarat, India. Engaging in drug formulation & development within the trade sector, it holds CIN: U24230GJ2010PTC062880. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹3.00 M and a paid-up capital of ₹3.00 M.
Formerly known as Nerve Biosciences Private Limited. It upholds a compliant status. Employing 21 professional, Its leadership includes Snehal Narendraprasad Vaishnav (Director), Viral Narendrabhai Shah (Director), Sandip Kulkarni Sureshrav (Director). Past directors included Bijjala Kavitha, Indravadan Pranshanker Bhatt, Bhumiben Satyajit Bhatt. It holds ₹2.20 Cr open charges and ₹1.10 Cr settled loans. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 301, Gold Leaf, Maradia Plaza Lane, Behind Law College, Off C.G. Road, Navra, Ngpura, Ahmedabad, Gujarat, 380009.
U24230GJ2010PTC062880
062880
11 November 2010
₹3.00 M
₹3.00 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Nephurocare Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Snehal Narendraprasad Vaishnav | Director | 04 Sep 2014 | Current |
| Viral Narendrabhai Shah | Director | 04 Sep 2014 | Current |
| Sandip Kulkarni Sureshrav | Director | 18 Sep 2014 | Current |
| Jashvant Patel Prahladbhai | Director | 10 Sep 2014 | Current |
| Shailesh Joshi Rameshchandra | Director | 01 Apr 2015 | Current |
| Satyajit Indravadan Bhatt | Director | 01 Mar 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Apr 2017 | Past |
| Pramod Abcsdd | Director | 17 Sep 2012 | Past |
| Pramod Abcsdd | Director | 01 Dec 2014 | Past |
| Pramod Abcsdd | Director | 15 Jun 2013 | Past |
| Pramod Abcsdd | Director | 13 Feb 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Nephurocare Pharma Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.86% increase. The company also saw a slight decrease in profitability, with a 2.19% decrease in profit. The company's net worth moved up by a moderate rise of 7.53%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Nephurocare Pharma had a public holding of 20.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹22,000,000.00
₹11,020,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Oct 2023 | Hdfc Bank Limited | ₹7.00 M | Open |
| 15 Jun 2023 | Hdfc Bank Limited | ₹1.50 Cr | Open |
| 28 Nov 2017 | Others | ₹7.02 M | Satisfied |
| 01 Mar 2017 | Others | ₹4.00 M | Satisfied |
Explore comprehensive loan charge details -
Nephurocare Pharma has a workforce of 21 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Nephurocare Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Nephurocare Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Nephurocare Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was documented.
Nephurocare Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was recorded as a recent event.
A charge with Hdfc Bank Limited of Rs. 15.00 M registered on 15 Jun 2023 with Charge ID 100769132 was modified on 12 Dec 2023. was recorded as a recent event.
The activity A charge with Hdfc Bank Limited amounted to Rs. 7.00 M with Charge ID 100819336 was registered on 04 Oct 2023. was completed.
A charge with Hdfc Bank Limited amounted to Rs. 15.00 M with Charge ID 100769132 was registered on 15 Jun 2023. was recorded as a recent event.
A charge registered on 28 Nov 2017 via Charge ID 100140522 with Others was fully satisfied on 15 Jun 2023. was recorded as a recent event.
The CIN of Nephurocare Pharma Private Limited is U24230GJ2010PTC062880.
Nephurocare Pharma Private Limited is headquartered at 301, Gold Leaf, Maradia Plaza Lane, Behind Law College, Off C.G. Road, Navra, Ngpura, Ahmedabad, Gujarat, 380009.
Nephurocare Pharma Private Limited was incorporated on 11 November 2010.
The current directors of Nephurocare Pharma Private Limited are
The primary industry of Nephurocare Pharma Private Limited is Trade.
Nephurocare Pharma Private Limited is unlisted.
The authorized capital of Nephurocare Pharma Private Limited is ₹3.00 M, and the paid-up capital is ₹3.00 M.
The compliance status of Nephurocare Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX